SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Credit Suisse Maintains Outperform on Integra Lifesciences, Raises Price Target to $58

Credit Suisse maintains Integra Lifesciences (NASDAQ:IART) with a Outperform and raises the price target from $56 to $58.

Benzinga · 05/08/2020 14:29

Credit Suisse maintains Integra Lifesciences (NASDAQ:IART) with a Outperform and raises the price target from $56 to $58.